Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen ...Middle East

TARRYTOWN, N.Y., Dec. 29, 2020 /PRNewswire/ -- Phase 3 program in hospitalized patients to continue based on passing futility analysis on ability to reduce incidence of death or mechanical ventilation As in earlier outpatient trial, immune status when patients entered the trial was a...

Read More Details
Finally We wish PressBee provided you with enough information of ( Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen )

Also on site :

• The 36 US bases on the frontline of Iranian retribution
• Target's 'Top-Selling' $5 Backpack Is Heading Back to Stores This Year
• NATO leaders gather Tuesday for what could be a historic summit, or one marred by divisions